The Effects of Apigenin in the Treatment of Diabetic Nephropathy: A Systematic Review of Non-clinical Studies

CONCLUSION: The results indicated that the use of apigenin could mitigate diabetes-induced renal adverse effects, mainly through its antioxidant, anti-apoptotic, and anti-inflammatory activities. Since the findings of this study are based on experimental studies, suggesting the use of apigenin (as a nephroprotective agent) against diabetic nephropathy requires further clinical studies.PMID:38282447 | DOI:10.2174/1389557523666230811092423

Source: Mini Reviews in Medicinal Chemistry - January 29, 2024 Category: Chemistry Authors: Thikra Majid Muhammed Abduladheem Turki Jalil Waam Mohammed Taher Zafar Aminov Fahad Alsaikhan Andr és Alexis Ramírez-Coronel Pushpamala Ramaiah Bagher Farhood Source Type: research